GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Life Science REIT PLC (LSE:LABS) » Definitions » ROE %

Life Science REIT (LSE:LABS) ROE % : -9.45% (As of Jun. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Life Science REIT ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Life Science REIT's annualized net income for the quarter that ended in Jun. 2024 was £-26.03 Mil. Life Science REIT's average Total Stockholders Equity over the quarter that ended in Jun. 2024 was £275.49 Mil. Therefore, Life Science REIT's annualized ROE % for the quarter that ended in Jun. 2024 was -9.45%.

The historical rank and industry rank for Life Science REIT's ROE % or its related term are showing as below:

LSE:LABS' s ROE % Range Over the Past 10 Years
Min: -13.88   Med: -7.2   Max: 2.21
Current: -13.88

During the past 3 years, Life Science REIT's highest ROE % was 2.21%. The lowest was -13.88%. And the median was -7.20%.

LSE:LABS's ROE % is ranked worse than
93.38% of 922 companies
in the REITs industry
Industry Median: 5 vs LSE:LABS: -13.88

Life Science REIT ROE % Historical Data

The historical data trend for Life Science REIT's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Life Science REIT ROE % Chart

Life Science REIT Annual Data
Trend Dec21 Dec22 Dec23
ROE %
2.21 -8.24 -7.20

Life Science REIT Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Get a 7-Day Free Trial 3.90 -20.39 3.36 -18.08 -9.45

Competitive Comparison of Life Science REIT's ROE %

For the REIT - Healthcare Facilities subindustry, Life Science REIT's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Life Science REIT's ROE % Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Life Science REIT's ROE % distribution charts can be found below:

* The bar in red indicates where Life Science REIT's ROE % falls into.



Life Science REIT ROE % Calculation

Life Science REIT's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-21.706/( (319.451+283.745)/ 2 )
=-21.706/301.598
=-7.20 %

Life Science REIT's annualized ROE % for the quarter that ended in Jun. 2024 is calculated as

ROE %=Net Income (Q: Jun. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Jun. 2024 ))/ count )
=-26.03/( (283.745+267.23)/ 2 )
=-26.03/275.4875
=-9.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Jun. 2024) net income data. ROE % is displayed in the 30-year financial page.


Life Science REIT  (LSE:LABS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-26.03/275.4875
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-26.03 / -18.5)*(-18.5 / 406.533)*(406.533 / 275.4875)
=Net Margin %*Asset Turnover*Equity Multiplier
=140.7 %*-0.0455*1.4757
=ROA %*Equity Multiplier
=-6.4 %*1.4757
=-9.45 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-26.03/275.4875
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-26.03 / -26.03) * (-26.03 / -18.5) * (-18.5 / 406.533) * (406.533 / 275.4875)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * 140.7 % * -0.0455 * 1.4757
=-9.45 %

Note: The net income data used here is two times the semi-annual (Jun. 2024) net income data. The Revenue data used here is two times the semi-annual (Jun. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Life Science REIT ROE % Related Terms

Thank you for viewing the detailed overview of Life Science REIT's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Life Science REIT Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
Life Science REIT PLC is the first London-listed REIT to focus on investment in properties in the life science sector in the UK. The company will invest in may include wet and dry laboratories, offices, incubators and co-working spaces, manufacturing and testing facilities, and data centers.

Life Science REIT Headlines